Technical Analysis for ANIP - ANI Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 56.08 0.61% 0.34
ANIP closed up 0.61 percent on Monday, November 18, 2019, on 40 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ANIP trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Bullish Engulfing Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Hammer Candlestick Bullish 0.61%
Lizard Bullish Bullish Day Trade Setup 0.61%
Narrow Range Bar Range Contraction 0.61%
Wide Bands Range Expansion 0.61%

Older signals for ANIP ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. It offers liquid, powder, oral solid dose, and cough/cold products; and antacids, laxatives, and other stomach remedies. The company also provides hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture, and metoclopramide tablets. In addition, ANI Pharmaceuticals offers contract manufacturing services for other pharmaceutical companies. It offers its products through wholesalers, smaller regional distributors and chains, and pharmacy and retail outlets in the United States. ANI Pharmaceuticals, Inc. was formerly known as ASHCO. The company was founded in 2001 and is based in Baudette, Minnesota. It has manufacturing facilities in Gulfport, Mississippi; and Baudette, Minnesota. ANI Pharmaceuticals, Inc. is a former subsidiary of Bactolac Pharmaceutical Inc.
Medicine Chemistry Pharmaceutical Retail Outlets Pharmacology Minnesota Chloroarenes Contract Manufacturing Services Cough Antiemetics Enema Metoclopramide Prolactin Releasers
Is ANIP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 86.96
52 Week Low 36.92
Average Volume 198,922
200-Day Moving Average 70.6109
50-Day Moving Average 71.197
20-Day Moving Average 69.0555
10-Day Moving Average 59.739
Average True Range 2.8387
ADX 43.01
+DI 10.8126
-DI 42.3783
Chandelier Exit (Long, 3 ATRs ) 72.3539
Chandelier Exit (Short, 3 ATRs ) 63.1461
Upper Bollinger Band 89.9327
Lower Bollinger Band 48.1783
Percent B (%b) 0.19
BandWidth 60.464988
MACD Line -5.0228
MACD Signal Line -3.1769
MACD Histogram -1.8459
Fundamentals Value
Market Cap 652.66 Million
Num Shares 11.6 Million
EPS 0.46
Price-to-Earnings (P/E) Ratio 121.91
Price-to-Sales 4.26
Price-to-Book 3.82
PEG Ratio 1.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 57.85
Resistance 3 (R3) 57.68 56.93 57.56
Resistance 2 (R2) 56.93 56.48 57.01 57.46
Resistance 1 (R1) 56.50 56.20 56.72 56.67 57.36
Pivot Point 55.75 55.75 55.85 55.83 55.75
Support 1 (S1) 55.32 55.30 55.54 55.49 54.80
Support 2 (S2) 54.57 55.02 54.65 54.70
Support 3 (S3) 54.14 54.57 54.61
Support 4 (S4) 54.31